醫療保健 · Healthcare
開啟互動頁面（K 線、成交價圖）Open interactive page →
DNTH · Dianthus Therapeutics, Inc. /DE/
內部人交易（Form 4）· Insider trading · 2026-07-01 – 2026-10-22
Dianthus Therapeutics, Inc. /DE/（DNTH）內部人交易：2026-07-01 至 2026-10-22，內部人公開市場買入 —、賣出 $29.3M；高管董事有效買入 —、有效賣出 —。最近申報 2026-09-18。
買入 Bought—
賣出 Sold$29.3M
有效買入 Effective bought—
有效賣出 Effective sold—
最近申報 Recent filings
| 交易日 | 內部人 | 類型 | 股數 | 價格 | 金額 | |
|---|---|---|---|---|---|---|
| 2026-09-17 | CARR EDWARD CHIEF ACCOUNTING OFFICER | 賣出 Sell | 20,000 | $101.38 | $2.0M | SEC |
| 2026-09-01 | Randhawa Simrat EVP, Head of R&D | 賣出 Sell | 23,124 | $106.41 | $2.5M | SEC |
| 2026-08-19 | Read Simon Director | 賣出 Sell | 2,778 | $117.55 | $327K | SEC |
| 2026-08-10 | Read Simon Director | 賣出 Sell | 2,777 | $109.55 | $304K | SEC |
| 2026-08-07 | Veness Adam M SVP, General Counsel and Sec. | 賣出 Sell | 20,000 | $110.44 | $2.2M | SEC |
| 2026-08-10 | McGeorge Anne Director | 賣出 Sell | 7,750 | $109.01 | $845K | SEC |
| 2026-08-07 | Garcia Marino CEO AND PRESIDENT, Director | 賣出 Sell | 166,000 | $108.11 | $17.9M | SEC |
| 2026-07-09 | Savitz Ryan EVP, CFO & CBO | 賣出 Sell | 31,249 | $101.03 | $3.2M | SEC |
「有效」= 高管或董事的公開市場主動買賣，排除 10b5-1 計劃、行權賣出、繳稅賣出、IPO/認購等。
擬出售 Form 144
| 預計出售日 | 申報人 | 股數 | 約金額 | |
|---|---|---|---|---|
| 2026-09-17 | CARR EDWARD Officer | 20,000 | $2.0M | 10b5-1 |
| 2026-09-01 | Randhawa Simrat Officer | 23,124 | $2.4M | 10b5-1 |
| 2026-08-10 | Veness Adam M Officer | 16,167 | $1.8M | 10b5-1 |
| 2026-08-10 | McGeorge Anne Director | 7,750 | $844K | 10b5-1 |
| 2026-08-10 | Read Simon Officer | 5,550 | $624K | 10b5-1 |
| 2026-08-07 | Garcia Marino Officer | 126,000 | $13.6M | |
| 2026-08-07 | Garcia Marino Director, Officer | 40,000 | $4.4M | 10b5-1 |
| 2026-08-07 | Veness Adam M Officer | 3,833 | $421K | 10b5-1 |
| 2026-07-09 | Savitz Ryan Officer | 31,249 | $3.1M | 10b5-1 |
內部人 Insiders
CARR EDWARD、Randhawa Simrat、Read Simon、Veness Adam M、McGeorge Anne、Garcia Marino、Savitz Ryan